| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |